2019 TAAB Symposium
In this year’s TAAB symposium, we will discuss issues related to new areas of breakthrough medicines and critical topics in the development of innovative treatment options. We will have speakers from academia and industry in the US to share their experiences and knowledge in those topics. We also dedicated a session for young Taiwanese researchers to show case their work and a session for net-working.
Theme
Breakthrough Medicine: Innovation and Challenge
When
Sat, December 7, 2019 8:00 AM – 6:00 PM EST
Where
Rutgers University Ernest Mario School of Pharmacy 160 Frelinghuysen Road Piscataway, NJ 08854 Pharmacy Room #130
Agenda
Max Li, Ph.D.
Vice President of TAAB
Director, Regulatory Affairs, CMC
Insmed
Yoke-Chen Chang, PhD
Assistant Research Professor, Ernest Mario School of Pharmacy, Rutgers University. Senior Councilor, Dermal Toxicology Specialty Section, Society of Toxicology
Sharon Lin, Ph.D
Senior Scientist
MustangBio
Hsing-I Ho, PhD
Associate research scientist Department of systems biology
Columbia university
Hsiao-Ling Hung, PhD
RAC Group Director, Global Regulatory Sciences Global Regulatory Strategy Lead, OPDIVO Lung Cancer Program Bristol-Myers Squibb
Shih-Han Lee, Ph.D
Research Associate
Cancer Biology and Genetics Program
Memorial Sloan Kettering Cancer Center
Yen-Hua Chen, PhD
Postdoctoral Research Associate
Weill Cornell Medicine Division of Pulmonary and Critical Care Medicine
Tai-Yi (Diana) Kuo, Ph D
Associate Research Scientist and Berrie Foundation Scholar
Columbia University Berrie Diabetes Center
NETWORKING AND COFFEE BREAK
Our Speaker
Max Li, Ph.D.
Vice President of TAAB Director, Regulatory Affairs, CMC Insmed
Yoke-Chen Chang, PhD
Assistant Research Professor, Ernest Mario School of Pharmacy, Rutgers University. Senior Councilor, Dermal Toxicology Specialty Section, Society of Toxicology
Sharon Lin, Ph.D
Senior Scientist MustangBio
Hsing-I Ho, PhD
Associate research scientist Department of systems biology Columbia university
Hsiao-Ling Hung, PhD
RAC Group Director, Global Regulatory Sciences Global Regulatory Strategy Lead, OPDIVO Lung Cancer Program Bristol-Myers Squibb
Shih-Han Lee, Ph.D
Research Associate Cancer Biology and Genetics Program Memorial Sloan Kettering Cancer Center
Yen-Hua Chen, PhD
Postdoctoral Research Associate Weill Cornell Medicine Division of Pulmonary and Critical Care Medicine
Tai-Yi (Diana) Kuo, Ph D
Associate Research Scientist and Berrie Foundation Scholar, Columbia University Berrie Diabetes Center
Information
Sponsors
